Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030
This is exactly why morning L-Carnitine has become so popular
What are the expected benefits of using Semaglutide GLP-1 for weight management
Nephrol Dial Transplant
Despite experiencing metabolic and cardiovascular improvements, many individuals using these drugs might retain underlying conditions such as diabetes, hypertension, dyslipidemia, sleep apnea, or fatty liver disease (MASLD)
While assessing BMI is an important first step, treatment decisions always involve thorough discussions with each patient to ensure that recommended therapies align with their unique health needs, goals, and preferences